These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of a prolonged anhepatic phase and PGE1 on intraoperative hemodynamic changes and graft survival in rat liver transplantation. Ware F; Goto S; Kamada N; Saito T; Moore T; Kobayashi E; Toyama N; Lord R; Stamatiou S; Kim YI Transplant Proc; 1994 Aug; 26(4):2265. PubMed ID: 8066745 [No Abstract] [Full Text] [Related]
5. Impact of preservation-induced liver injury on the risk of rejection of rat and human liver grafts. Bao YM; Adam R; Farges O; Astarcioglu I; Sebagh M; Saoudi S; Bismuth H Transplant Proc; 1995 Aug; 27(4):2502-3. PubMed ID: 7652903 [No Abstract] [Full Text] [Related]
6. Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation. Takaya S; Doyle H; Todo S; Irish W; Fung JJ; Starzl TE Transplant Proc; 1995 Apr; 27(2):1862-7. PubMed ID: 7725533 [No Abstract] [Full Text] [Related]
7. Evaluation of serum IL-8 concentrations after orthotopic liver transplantation in rats. Yagihashi A; Zou XM; Hirata K; Asanuma K; Tsuruma T; Matsuno T; Yamaguchi H; Yamashiro K; Koide S; Torimoto K Transplant Proc; 1995 Apr; 27(2):1632-3. PubMed ID: 7725431 [No Abstract] [Full Text] [Related]
8. Importance of early arterialization of the liver graft. Rasmussen A; Palfelt I; Larsen PN; Hjortrup A; Kirkegaard P Transplant Proc; 1994 Jun; 26(3):1790. PubMed ID: 8030137 [No Abstract] [Full Text] [Related]
9. Combined procurement of liver and pancreas does not influence early graft function and survival. Kim SC; Lee SG; Han DJ; Lee YJ; Kwon TW; Park KM; Choi BW; Min PC Transplant Proc; 1996 Jun; 28(3):1882-4. PubMed ID: 8658929 [No Abstract] [Full Text] [Related]
10. Impact of glycogen content of the donor liver in clinical liver transplantation. Adam R; Reynes M; Bao YM; Astarcioglu I; Azoulay D; Chiche L; Bismuth H Transplant Proc; 1993 Feb; 25(1 Pt 2):1536-7. PubMed ID: 8442179 [No Abstract] [Full Text] [Related]
11. Maintenance immunosuppression using cyclosporine monotherapy in adult orthotopic liver transplant recipients. Tchervenkov JI; Tector AJ; Cantarovich M; Tahta SA; Asfar A; Naimi J; Elias N; Barkun J Transplant Proc; 1996 Aug; 28(4):2247-9. PubMed ID: 8769214 [No Abstract] [Full Text] [Related]
12. Impact of selective prostaglandin E1 treatment on graft perfusion and function after liver transplantation. Kornberg A; Schotte U; Kupper B; Hommann M; Scheele J Hepatogastroenterology; 2004; 51(56):526-31. PubMed ID: 15086195 [TBL] [Abstract][Full Text] [Related]
13. Platelet activating factor antagonist has a protective effect on preservation/reperfusion injury of the graft in pig liver transplantation. Takada Y; Boudjema K; Jaeck D; Chenard MP; Wolf P; Cinqualbre J; Yamaoka Y Transplant Proc; 1995 Feb; 27(1):747-8. PubMed ID: 7879169 [No Abstract] [Full Text] [Related]
14. Liver transplantation from elderly donors. Adam R; Astarcioglu I; Azoulay D; Chiche L; Bao YM; Castaing D; Bismuth H Transplant Proc; 1993 Feb; 25(1 Pt 2):1556-7. PubMed ID: 8442187 [No Abstract] [Full Text] [Related]
15. Human hepatocyte growth factor serum levels in early stages after orthotopic liver transplantation. Hrusovsky S; Tsubouchi H; Remy-Martin A; Jouvenot M; Adessi GL; Rouget C; Mantion G; Heyd B; Chabod P; Bresson S Transplant Proc; 1994 Dec; 26(6):3618-9. PubMed ID: 7998295 [No Abstract] [Full Text] [Related]
16. Donor characteristics for liver transplantation and risk factors for early poor graft function and survival. Lee YJ; Lee SG; Kwon TW; Park KM; Kim SC; Min PC Transplant Proc; 1996 Jun; 28(3):1663-4. PubMed ID: 8658828 [No Abstract] [Full Text] [Related]